Etoposide, ifosfamide and cisplatin (VIP) plus concurrent radiation therapy for previously untreated limited small cell lung cancer (SCLC): A Hoosier Oncology Group (HOG) phase II study

Nasser Hanna, Rafat Ansari, William Fisher, Jianzhao Shen, Sin Ho Jung, Alan Sandler

Research output: Contribution to journalArticle

16 Scopus citations

Fingerprint Dive into the research topics of 'Etoposide, ifosfamide and cisplatin (VIP) plus concurrent radiation therapy for previously untreated limited small cell lung cancer (SCLC): A Hoosier Oncology Group (HOG) phase II study'. Together they form a unique fingerprint.

Medicine & Life Sciences